Indigo Biosciences Inc.

State College, PA · Founded 2007 · CIK 0001500149 · Biotech · Private

Cell-based assay platform and services for drug testing and toxicology screening

indigobiosciences.com →
Grants
—
No SBIR or STTR on record
Sector median: 1
Raised
$782K
2 Form D · Oct 2011
180 months since last filing
Contracts
—
No federal contracts on record
Patents
—
No published records under this name
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Private capital raisedForm D · SEC$100,000
Private capital raisedForm D · SEC$682,000
Form D · SEC

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
2582KaloCyte Inc—$800K
2583Metagenomi——
2584PRAETEGO, INC.—$783K
2585Indigo Biosciences Inc.—$782K
2586Bit Discovery, Inc.—$760K
2587AAKHA BIOLOGICS INC.—$750K
2588ENDURE BIOTHERAPEUTICS, INC.——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Founders & Team

From Form D filings · 5 related persons
  • H. BunnellDirector · Executive Officer
  • Steven CarpenterDirector
  • Blake PetersonDirector
  • Richard PilstonDirector
  • Jack Vanden HuevelDirector

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.